Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention

NCT04962373 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT04962373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention
Lead sponsor
Region Skane
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
June 30, 2025
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-suicidal self injury, self-harm, deliberate, suicidal, suicide, attempted